» Articles » PMID: 36511702

Distinct Molecular Features of NleG Type 3 Secreted Effectors Allow for Different Roles During Citrobacter Rodentium Infection in Mice

Overview
Journal Infect Immun
Date 2022 Dec 13
PMID 36511702
Authors
Affiliations
Soon will be listed here.
Abstract

The NleGs are the largest family of type 3 secreted effectors in attaching and effacing (A/E) pathogens, such as enterohemorrhagic Escherichia coli (EHEC), enteropathogenic E. coli, and Citrobacter rodentium. NleG effectors contain a conserved C-terminal U-box domain acting as a ubiquitin protein ligase and target host proteins via a variable N-terminal portion. The specific roles of these effectors during infection remain uncertain. Here, we demonstrate that the three NleG effectors-NleG1, NleG7, and NleG8-encoded by C. rodentium DBS100 play distinct roles during infection in mice. Using individual knockout strains, we show that NleG7 contributes to bacterial survival during enteric infection while NleG1 promotes the expression of diarrheal symptoms and NleG8 contributes to accelerated lethality in susceptible mice. Furthermore, the NleG8 effector contains a C-terminal PDZ domain binding motif that enables interaction with the host protein GOPC. Both the PDZ domain binding motif and the ability to engage with host ubiquitination machinery via the intact U-box domain proved to be necessary for NleG8 function, contributing to the observed phenotype during infection. We also establish that the PTZ binding motif in the EHEC NleG8 (NleG8) effector, which shares 60% identity with NleG8, is engaged in interactions with human GOPC. The crystal structure of the NleG8 C-terminal peptide in complex with the GOPC PDZ domain, determined to 1.85 Å, revealed a conserved interaction mode similar to that observed between GOPC and eukaryotic PDZ domain binding motifs. Despite these common features, does not complement the Δ phenotype during infection, revealing functional diversification between these NleG effectors.

Citing Articles

Modulation of virulence by a novel SPI-2 injectisome effector that interacts with the dystrophin-associated protein complex.

Yu X, Xie H, Li Y, Liu M, Hou R, Predeus A mBio. 2024; 15(7):e0112824.

PMID: 38904384 PMC: 11253597. DOI: 10.1128/mbio.01128-24.


An acetyltransferase effector conserved across species targets the eukaryotic eIF3 complex to modulate protein translation.

Syriste L, Patel D, Stogios P, Skarina T, Patel D, Savchenko A mBio. 2024; 15(3):e0322123.

PMID: 38335095 PMC: 10936415. DOI: 10.1128/mbio.03221-23.

References
1.
Edwards R, Keller L, Schifferli D . Improved allelic exchange vectors and their use to analyze 987P fimbria gene expression. Gene. 1998; 207(2):149-57. DOI: 10.1016/s0378-1119(97)00619-7. View

2.
Amacher J, Cushing P, Bahl C, Beck T, Madden D . Stereochemical determinants of C-terminal specificity in PDZ peptide-binding domains: a novel contribution of the carboxylate-binding loop. J Biol Chem. 2012; 288(7):5114-26. PMC: 3576116. DOI: 10.1074/jbc.M112.401588. View

3.
Behrends C, Harper J . Constructing and decoding unconventional ubiquitin chains. Nat Struct Mol Biol. 2011; 18(5):520-8. DOI: 10.1038/nsmb.2066. View

4.
Lee H, Zheng J . PDZ domains and their binding partners: structure, specificity, and modification. Cell Commun Signal. 2010; 8:8. PMC: 2891790. DOI: 10.1186/1478-811X-8-8. View

5.
Tse C, In J, Yin J, Donowitz M, Doucet M, Foulke-Abel J . Enterohemorrhagic (EHEC)-Secreted Serine Protease EspP Stimulates Electrogenic Ion Transport in Human Colonoid Monolayers. Toxins (Basel). 2018; 10(9). PMC: 6162544. DOI: 10.3390/toxins10090351. View